XML 32 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities      
Net income $ 285,813 $ 217,968 $ 246,440
Adjustments to reconcile net income to net cash provided by operating activities      
Non-cash compensation expense 28,154 24,031 21,899
Amortization of deferred fees on loans and debt securities (47,093) (38,373) (40,345)
Amortization of deferred financing costs and premiums/discount on debt obligations 28,097 21,988 19,339
Gain on investments at fair value     (13,420)
Income from equity investment in unconsolidated subsidiary     (3,187)
Distributions of income from unconsolidated subsidiary     9,977
Changes in assets and liabilities, net      
Other assets (23,352) (4,632) 6,069
Other liabilities 18,383 6,479 (10,120)
Net cash provided by operating activities 290,002 227,461 236,652
Cash flows from investing activities      
Origination and fundings of loans receivable (7,890,051) (3,598,166) (3,151,882)
Principal collections and sales proceeds from loans receivable 3,084,747 2,780,431 3,514,429
Loan contributed to securitization 512,002    
Investment in debt securities held-to-maturity (95,937)    
Origination and exit fees received on loans receivable 104,408 55,441 44,697
Receipts under derivative financial instruments 47,527 6,453 41,573
Payments under derivative financial instruments (18,475) (20,870) (14,730)
Return of collateral deposited under derivative agreements 43,110 16,120  
Collateral deposited under derivative agreements (38,990) (20,161)  
Net cash (used in) provided by investing activities (4,251,659) (780,752) 434,087
Cash flows from financing activities      
Borrowings under secured debt agreements 9,183,852 4,306,301 3,185,933
Repayments under secured debt agreements (5,413,070) (4,778,194) (3,534,803)
Proceeds from issuance of collateralized loan obligations   817,500  
Proceeds from sale of loan participations 99,696 80,706 54,441
Repayment of loan participations (85,875) (381,310) (136,000)
Payment of deferred financing costs (25,006) (27,465) (15,350)
Contributions from non-controlling interests 9,315 12,165  
Distributions to non-controlling interests (5,907) (6,162) (21,070)
Net proceeds from issuance of convertible notes 214,775 394,632  
Repayment of convertible notes (219,232)    
Net proceeds from issuance of class A common stock 476,420 391,558 27
Dividends paid on class A common stock (277,260) (234,989) (232,775)
Net cash provided by (used in) financing activities 3,957,708 574,742 (699,597)
Net (decrease) increase in cash, cash equivalents, and restricted cash (3,949) 21,451 (28,858)
Cash, cash equivalents, and restricted cash at beginning of year 102,518 75,567 106,006
Effects of currency translation on cash, cash equivalents, and restricted cash 7,093 5,500 (1,581)
Cash, cash equivalents, and restricted cash at end of year 105,662 102,518 75,567
Supplemental disclosure of cash flows information      
Payments of interest (318,919) (206,966) (164,905)
Payments of income taxes (554) (296) (286)
Supplemental disclosure of non-cash investing and financing activities      
Dividends declared, not paid (76,530) (66,888) (58,615)
Loan principal payments held by servicer, net $ 4,855 15,763 $ 670
Consolidation of loans receivable of a VIE   500,000  
Consolidation of securitized debt obligations of a VIE   $ (474,620)